T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Essent Group
ESNT
$6.23B
| $92.7M | 0.01% |
2,250,395
+671
| +0% | +$29.9K |
|
|
MODV
752
DELISTED
ModivCare
MODV
| $92.7M | 0.01% |
803,680
-824
| -0.1% | -$95.1K |
|
753
iRhythm Holdings
IRTC
$4.06B
| $92.4M | 0.01% |
586,699
+62,194
| +12% | +$7.99M |
|
754
Emerson Electric
EMR
$91.6B
| $90.8M | 0.01% |
926,391
-44,604
| -5% | -$4.22M |
|
755
Semtech
SMTC
$12.4B
| $90.6M | 0.01% |
1,306,464
-138,868
| -10% | -$9.97M |
|
756
Newmont
NEM
$120B
| $90.3M | 0.01% |
1,136,693
-60,113
| -5% | -$4.07M |
|
757
Boston Scientific
BSX
$74.9B
| $90.2M | 0.01% |
2,037,461
-3,778,489
| -65% | -$164M |
|
758
Middlesex Water
MSEX
$1.11B
| $90.2M | 0.01% |
857,622
-651,673
| -43% | -$66.4M |
|
759
United Airlines
UAL
$41B
| $89.9M | 0.01% |
1,939,870
+68,770
| +4% | +$2.98M |
|
|
SAFE
760
DELISTED
Safehold Inc.
SAFE
| $89.7M | 0.01% |
1,617,970
+441,227
| +37% | +$27.3M |
|
761
Federal Signal
FSS
$7.51B
| $89.5M | 0.01% |
2,650,740
+350,655
| +15% | +$13.1M |
|
762
Churchill Downs
CHDN
$6.2B
| $89.4M | 0.01% |
805,980
-63,452
| -7% | -$6.98M |
|
763
Encore Capital Group
ECPG
$2.15B
| $89M | 0.01% |
1,419,316
-3,858
| -0.3% | -$252K |
|
764
Guardant Health
GH
$21.4B
| $89M | 0.01% |
1,343,067
+33,150
| +3% | +$2.27M |
|
765
Sarepta Therapeutics
SRPT
$1.95B
| $88.8M | 0.01% |
1,136,805
+401,247
| +55% | +$30.7M |
|
766
Fair Isaac
FICO
$24B
| $88.5M | 0.01% |
189,638
+49,347
| +35% | +$23.3M |
|
|
DFS
767
DELISTED
Discover Financial Services
DFS
| $88.1M | 0.01% |
799,594
+19,201
| +2% | +$2.26M |
|
768
Royalty Pharma
RPRX
$26.1B
| $88.1M | 0.01% |
2,261,199
-16,360
| -0.7% | -$642K |
|
769
Kearny Financial
KRNY
$604M
| $88M | 0.01% |
6,831,640
+3,003,888
| +78% | +$39.8M |
|
|
AIRC
770
DELISTED
Apartment Income REIT Corp.
AIRC
| $87.7M | 0.01% |
1,640,137
-1,074,549
| -40% | -$56.7M |
|
|
NBP
771
NovaBridge Biosciences American Depositary Shares
NBP
$220M
| $87.6M | 0.01% |
5,395,157
-1,953,615
| -27% | -$50.1M |
|
772
10x Genomics
TXG
$7.58B
| $87.5M | 0.01% |
1,150,753
+73,541
| +7% | +$6.43M |
|
773
Steven Madden
SHOO
$3.46B
| $87.5M | 0.01% |
2,263,414
+4,711
| +0.2% | +$195K |
|
|
RAPT
774
DELISTED
RAPT Therapeutics
RAPT
| $87.4M | 0.01% |
496,838
+3,377
| +0.7% | +$638K |
|
|
FBMS
775
DELISTED
The First Bancshares, Inc.
FBMS
| $86.9M | 0.01% |
2,582,259
-16,884
| -0.6% | -$613K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.